Skip to main content

Yaz Lawsuit Cites Bayer’s Lack of Blood Clot Risk Warning

By September 16, 2013November 1st, 2017Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_side_effects_lawsuits_dvt_blood_clot_settlementsIn early September, a woman who suffered from a deep vein thrombosis (DVT) in her right leg two years ago filed a Yaz lawsuit. According to a recent article in The Pennsylvania Record, the plaintiff, Dana Dougherty, filed her Yaz lawsuit alleging that the hormone present in Yaz, drospirenone, led to her health problems.

The lawsuit goes on to claim that the maker of Yaz, Bayer Pharmaceuticals, put the oral contraceptive on the market neglecting to include proper warnings about the risks of blood clots, DVT, and other serious side effects.

In a warning released by the U.S. Food and Drug Administration (FDA) in April 2012, they provided information about the association between oral contraceptives that contain the hormone drospirenone, such as Yaz and Yasmin, and the increased risk of developing a blood clot. The FDA pointed out that, according to currently available information, blood clot formation has a stronger link to drospirenone oral contraceptives than oral contraceptives that contain other types of hormones.

The British Medical Journal published an oft-cited study in August 2009 about the increased risk of blood clot development in patients using different types of oral contraceptives. When looking at patients using an oral contraceptive containing drospirenone, the researchers recorded a six-fold increase in the risk of blood clot formation when compared to individuals not using an oral contraceptive.

Researchers have also reported a considerably increased risk of blood clot formation and other venous complications during the first six months of using a drospirenone-containing oral contraceptive like Yaz, Yasmin, or Ocella.

As a national law firm that represents women who claim to have been injured by the use of Yaz, Yasmin, or Ocella, Carey Danis & Lowe has provided expert legal counsel in numerous cases that cite similar claims about insufficient warning about blood clot risks.

In addition to the risk of blood clot formation, plaintiffs who have filed Yaz and Yasmin lawsuits have also linked the oral contraceptives to heart attack, stroke, brain hemorrhage, and pulmonary embolism.

Carey Danis & Lowe Yaz and Yasmin lawyers are currently taking cases. For a free legal evaluation and to speak with one of our medical experts, contact Carey Danis & Lowe today to learn about your legal options.

Share your story with Carey Danis & Lowe by calling us at 800.721.2519, or by submitting a personal injury claim form.